BofA raised the firm’s price target on Alignment Healthcare (ALHC) to $18.50 from $15.50 and keeps a Buy rating on the shares after the company had “a markedly stronger quarter than most of ...
Stephens reiterated an “overweight” rating and set a $17.00 target price on shares of Alignment Healthcare in a research report on Monday, February 24th. Piper Sandler boosted their price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback